VITLS INC.

Profile

Company Names

VITLS INC.

Addresses

2450 HOLCOMBE BLVD., SUITE X+210, C/O TMCX MED CENTRE INNOVATION INSTITUTE, HOUSTON, TX 77021

2450 HOLCOMBE BLVD., SUITE X210, C/O TMC INNOVATION INSTITUTE, HOUSTON, TX 77021

2450 HOLCOMBE BLVD., SUITE X, C/O TMCX MED CENTRE INNOVATION INSTITUTE, HOUSTON, TX 77021

Phone Numbers

(415) 949-9963

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$7,236,513.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2022-11-14 
$1,311,301.00 
$2,000,000.00 
$688,699.00 
 
3
2021-10-28 
$4,475,212.00 
$5,335,212.00 
$860,000.00 
Equity 
2
2018-07-30 
$1,065,000.00 
$1,065,000.00 
$0.00 
Debt 
1
2017-05-10 
$385,000.00 
$385,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GREG 
 
CAMPBELL 
DIRECTOR
VITLS INC.   |  NEWTON GOLF COMPANY, INC.
CADELL 
 
LIEDTKE 
DIRECTOR
VITLS INC.
GREG 
 
MOSS 
DIRECTOR
VITLS INC.   |  ANTERIS TECHNOLOGIES GLOBAL CORP.
GREGORY 
 
MOSS 
DIRECTOR
VITLS INC.   |  EVOMMUNE, INC.
LOUISE 
 
VORSTER 
EXECUTIVE OFFICER, DIRECTOR
VITLS INC.
WERNER 
 
VORSTER 
EXECUTIVE OFFICER, DIRECTOR
VITLS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-11-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2022-11-14 
2021-11-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-28 
2018-12-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-05-10 
2018-08-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-07-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#